Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...
Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...
People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis ...
1h
Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...
Patients with COPD plus a depression/anxiety disorder had poorer scores related to disease burden and health-related quality of life, according to data published in Chronic Obstructive Pulmonary ...
Adults who had an above-average BMI, overweight or obesity during childhood have increased risk for developing chronic ...
Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...
Interstitial lung abnormalities are more prevalent in individuals with PRISm, and those with PRISm and ILAs have higher all-cause mortality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback